Topic: CPRIT

Common Antifungal Drug Decreases Tumor Growth and Shows Promise as Cancer Therapy

Aug. 21, 2012

An inexpensive antifungal drug, thiabendazole, slows tumor growth and shows promise as a chemotherapy for cancer. Scientists in the College of Natural Sciences at The University of Texas at Austin made this discovery by exploiting the evolutionary relatedness of yeast, frogs, mice and humans.

Read more

$3.3 Million in New Grants to Help Diagnose and Treat Cancer

Jan. 22, 2010

Three engineering research projects at The University of Texas at Austin--a protein therapy for liver cancer, an antibody therapy for cancer treatment and an immunity booster to respond to cancer--received $3.3 million from the Cancer Prevention and Research Institute of Texas.

Read more